Israeli biotech Nutrinia develops treatments for intestinal failure in preterms, infants and adults. Its NTRA-9620 treatment has just been granted orphan status by the US FDA.
Treating gastro problems with newborns
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.